Cargando…
Identification of Novel Autoantibodies for Detection of Malignant Mesothelioma
BACKGROUND: The malignant mesothelioma (MM) survival rate has been hampered by the lack of efficient and accurate early detection methods. The immune system may detect the early changes of tumor progression by responding with tumor-associated autoantibody production. Hence, in this study, we transla...
Autores principales: | Zhang, Xufei, Shen, Weike, Dong, Xiaomin, Fan, Jiangping, Liu, Lixia, Gao, Xu, Kernstine, Kemp H., Zhong, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747111/ https://www.ncbi.nlm.nih.gov/pubmed/23977302 http://dx.doi.org/10.1371/journal.pone.0072458 |
Ejemplares similares
-
A novel autoantibody test for the detection of pre-neoplastic lung lesions
por: Lowe, Frazer J, et al.
Publicado: (2014) -
Autoantibodies as potential biomarkers for breast cancer
por: Zhong, Li, et al.
Publicado: (2008) -
Identification of tumor antigens in malignant mesothelioma
por: Kim, Ye-Rin, et al.
Publicado: (2017) -
p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001) -
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)